QUARTERLY FINANCIAL STATEMENTS (UNAUDITED) (Parenthetical) (Details 1) - USD ($) |
Dec. 31, 2019 |
Sep. 30, 2019 |
Dec. 31, 2018 |
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Quarterly Financial Data [Line Items] | |||||||||||||||||||
Preferred stock, par value (in dollars per share) | $ 0.001 | $ 0.001 | $ 0.001 | ||||||||||||||||
Preferred stock, authorized | 15,000,000 | 15,000,000 | 15,000,000 | ||||||||||||||||
Preferred stock, issued | 0 | 0 | 0 | ||||||||||||||||
Preferred stock, outstanding | 0 | 0 | 0 | ||||||||||||||||
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 | $ 0.001 | ||||||||||||||||
Common stock, authorized | 250,000,000 | 250,000,000 | 250,000,000 | ||||||||||||||||
Common stock, issued | 48,471,446 | 47,671,446 | 37,341,393 | ||||||||||||||||
Common stock, outstanding | 48,471,446 | 47,671,446 | 37,341,393 | ||||||||||||||||
Decrease in short-term convertible notes payable | $ 2,995,000 | $ 2,928,000 | $ 11,253,000 | ||||||||||||||||
Decrease in long-term convertible notes payable | 5,485,000 | ||||||||||||||||||
Increase (decrease) in additional paid-in capital | 215,207,000 | 212,619,000 | 149,682,000 | ||||||||||||||||
Increase in equity method investment | 13,325,000 | 13,407,000 | 13,569,000 | ||||||||||||||||
Increase (decrease) in accounts payable and accrued expenses | 11,498,000 | 10,926,000 | 8,235,000 | ||||||||||||||||
Increase (decrease) in cash and cash equivalent | 1,769,000 | 1,326,000 | 3,905,000 | ||||||||||||||||
Decrease in prepaid expenses and other current assets | 1,402,000 | 1,541,000 | 634,000 | ||||||||||||||||
Increase in accounts receivable | 2,150,000 | 1,982,000 | 1,788,000 | ||||||||||||||||
Increase on current liability | 32,827,000 | 31,371,000 | 45,557,000 | ||||||||||||||||
Increase in other current liability | 5,748,000 | 6,033,000 | 5,342,000 | ||||||||||||||||
Increase in warrant derivative liabilities | $ 38,000 | 91,000 | 8,939,000 | ||||||||||||||||
Adjustments [Member] | |||||||||||||||||||
Quarterly Financial Data [Line Items] | |||||||||||||||||||
Increase (decrease) in additional paid-in capital | 13,224,000 | [1],[2] | 8,779,000 | [3],[4],[5] | |||||||||||||||
Increase in equity method investment | 13,407,000 | [1] | 13,569,000 | [6] | |||||||||||||||
Increase (decrease) in accounts payable and accrued expenses | 220,000 | [1] | (887,000) | [6] | |||||||||||||||
Increase in noncontrolling interest | 725,000 | 97,000 | [6] | ||||||||||||||||
Increase (decrease) in cash and cash equivalent | (12,220,000) | [1] | (13,175,000) | [6] | |||||||||||||||
Decrease in prepaid expenses and other current assets | 347,000 | [1],[7] | (109,000) | [4],[6] | |||||||||||||||
Increase in accounts receivable | 82,000 | [7] | 437,000 | [4] | |||||||||||||||
Increase on current liability | (3,862,000) | 8,031,000 | |||||||||||||||||
Increase in other current liability | 357,000 | [2],[7] | 161,000 | [4] | |||||||||||||||
Increase in warrant derivative liabilities | 91,000 | [2] | 8,939,000 | [4],[5] | |||||||||||||||
Adjustments [Member] | Senior Secured Debentures [Member] | |||||||||||||||||||
Quarterly Financial Data [Line Items] | |||||||||||||||||||
Decrease in short-term convertible notes payable | (4,500,000) | ||||||||||||||||||
Decrease in long-term convertible notes payable | (500,000) | ||||||||||||||||||
Increase (decrease) in additional paid-in capital | (5,600,000) | ||||||||||||||||||
Decrease in short-term conversion feature liabilities | (263,000) | ||||||||||||||||||
Decrease long-term conversion feature liabilities | (29,000) | ||||||||||||||||||
Adjustments [Member] | Variable Consideration [Member] | |||||||||||||||||||
Quarterly Financial Data [Line Items] | |||||||||||||||||||
Increase (decrease) in accounts payable and accrued expenses | (946,000) | ||||||||||||||||||
Increase in accounts receivable | 82,000 | 436,000 | |||||||||||||||||
Increase on current liability | 22,000 | ||||||||||||||||||
Adjustments [Member] | Financing Agreement On Insurance Premium [Member] | |||||||||||||||||||
Quarterly Financial Data [Line Items] | |||||||||||||||||||
Increase on current liability | 141,000 | ||||||||||||||||||
Increase on prepaid expenses | 598,000 | 141,000 | |||||||||||||||||
Increase in other current liability | 598,000 | ||||||||||||||||||
Adjustments [Member] | Debt Modification Accounting [Member] | |||||||||||||||||||
Quarterly Financial Data [Line Items] | |||||||||||||||||||
Increase (decrease) in additional paid-in capital | 1,100,000 | ||||||||||||||||||
Adjustments [Member] | Warrant Adjustments [Member] | |||||||||||||||||||
Quarterly Financial Data [Line Items] | |||||||||||||||||||
Increase (decrease) in additional paid-in capital | (776,000) | (9,700,000) | |||||||||||||||||
Increase in warrant derivative liabilities | 91,000 | 7,500,000 | |||||||||||||||||
Adjustments [Member] | EJ Holding, Inc. [Member] | |||||||||||||||||||
Quarterly Financial Data [Line Items] | |||||||||||||||||||
Increase in equity method investment | 13,400,000 | 13,600,000 | |||||||||||||||||
Increase (decrease) in accounts payable and accrued expenses | 220,000 | 58,000 | |||||||||||||||||
Increase in noncontrolling interest | 725,000 | 97,000 | |||||||||||||||||
Increase (decrease) in cash and cash equivalent | (12,200,000) | (13,200,000) | |||||||||||||||||
Decrease in prepaid expenses and other current assets | $ (241,000) | $ (240,000) | |||||||||||||||||
|